Adjuvant ovarian suppression for resected breast cancer: 2017 critical assessment Steven E. Vogl Editorial 10 July 2017 Pages: 1 - 13
Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review Christie YaoLori J. BernsteinJill B. Rich Review 13 July 2017 Pages: 15 - 28
Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast Lumarie SantiagoBeatriz E. AdradaRosalind P. Candelaria Review 20 July 2017 Pages: 29 - 39
Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib Dorota Kwapisz Review 24 July 2017 Pages: 41 - 54
A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells Yoko ChiharaMasafumi ShimodaShinzaburo Noguchi Preclinical study 12 July 2017 Pages: 55 - 68
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer Gulisa TurashviliJoanne F. ChouHannah Y. Wen Preclinical study 12 July 2017 Pages: 69 - 76
Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer Lei GuoPei YuanLixue Xuan Preclinical study 15 July 2017 Pages: 77 - 84
Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome P. MillerK. M. KidwellM. E. Lippman Preclinical study 17 July 2017 Pages: 85 - 94
Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients Hang LiuJingxuan WangQingyuan Zhang Preclinical study 20 July 2017 Pages: 95 - 107
A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy Meng ShiFei MaMing Yang Preclinical study 25 July 2017 Pages: 109 - 116
Functional importance of PP2A regulatory subunit loss in breast cancer Lauren F. WattNikita PanickerNicole M. Verrills Preclinical study 25 July 2017 Pages: 117 - 131
Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution Melody L. Stallings-MannEthan P. HeinzenDerek C. Radisky Preclinical study Open access 27 July 2017 Pages: 133 - 143
Predictors associated with MRI surveillance screening in women with a personal history of unilateral breast cancer but without a genetic predisposition for future contralateral breast cancer John V. HegdeXiaoyan WangSusan A. McCloskey Clinical trial 12 July 2017 Pages: 145 - 156
Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography Kathleen Van DykAimee M. HunterPatricia A. Ganz Clinical trial 13 July 2017 Pages: 157 - 166
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancer Florence R. WilsonAbhishek VaruShrividya Iyer Clinical trial Open access 27 July 2017 Pages: 167 - 177
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers Cesar A. Santa-MariaMegan KruseAlberto J. Montero Clinical trial 27 July 2017 Pages: 179 - 184
Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women María Elena MartínezScarlett L. GomezChristopher Li Epidemiology 11 July 2017 Pages: 185 - 193
Erratum to: Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women María Elena MartínezScarlett L. GomezChristopher Li Erratum 04 September 2017 Pages: 195 - 195
Adiposity during early adulthood, changes in adiposity during adulthood, attained adiposity, and mammographic density among premenopausal women Aliya AlimujiangCatherine AppletonAdetunji T. Toriola Epidemiology 12 July 2017 Pages: 197 - 206
Medical costs of treating breast cancer among younger Medicaid beneficiaries by stage at diagnosis Justin G. TrogdonDonatus U. EkwuemeBenjamin T. Allaire Epidemiology 12 July 2017 Pages: 207 - 215
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population Johanna I. KiiskiAnna TervasmäkiHeli Nevanlinna Epidemiology Open access 12 July 2017 Pages: 217 - 226
Breast cancer risk prediction: an update to the Rosner–Colditz breast cancer incidence model Megan S. RiceShelley S. TworogerBernard Rosner Epidemiology 12 July 2017 Pages: 227 - 240
Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer Anthony F. YuRoy B. MukkuChau T. Dang Epidemiology 14 July 2017 Pages: 241 - 247
Radiation-related heart disease after breast cancer radiation therapy in Korean women Jee Suk ChangByung Kyun KoKorean Breast Cancer Society Epidemiology 17 July 2017 Pages: 249 - 257
Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors Dounya SchoormansLonneke van de Poll-FranseJohan Denollet Epidemiology Open access 17 July 2017 Pages: 259 - 266
Diagnosis and treatment delays among elderly breast cancer patients with pre-existing mental illness Kristy IglayMelissa L. SantorelliKitaw Demissie Epidemiology 19 July 2017 Pages: 267 - 275
CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study D. L. HertzK. M. KidwellJ. M. Rae Epidemiology 20 July 2017 Pages: 277 - 287
Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study Wenyu WuJie ChenJian Zhang Epidemiology 24 July 2017 Pages: 289 - 297
Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers Diana R. WithrowLindsay M. MortonAmy Berrington de González Epidemiology 25 July 2017 Pages: 299 - 306
Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer Jacky D. LuitenAdri C. VoogdLucien E. M. Duijm Epidemiology 26 July 2017 Pages: 307 - 314
Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient Scolastica W. NjorogeKelly R. BurgessLydia Usha Brief Report 12 July 2017 Pages: 315 - 319
Letter to the editor: In response to “influence of clinical, societal, and treatment variables on racial difference in ER-/PR- breast cancer survival” by Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS Constance Hilliard Letter to the Editor 10 July 2017 Pages: 321 - 322
Comments on “Primary tumor location predicts the site of local relapse after nipple–areola complex (NAC) sparing mastectomy” by Cont et al. Breast Cancer Res Treat, 2017 Stephen R. GrobmyerRisal Djohan Letter to the Editor 25 July 2017 Pages: 323 - 324
Erratum to: Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells Daniela BonofiglioSabrina GabrieleSebastiano Andò Erratum 18 August 2017 Pages: 325 - 326
Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Javier CortésHope S. RugoJoyce O’Shaughnessy Erratum 07 September 2017 Pages: 327 - 328
